Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1Gastrointestinal 1Endocrine 1

Conditions

Breast Neoplasms 300Carcinoma, Non-Small-Cell Lung 262Neoplasms 242Prostatic Neoplasms 204Colorectal Neoplasms 187Lung Neoplasms 145Multiple Myeloma 141Neoplasm Metastasis 126Ovarian Neoplasms 123Leukemia, Myeloid, Acute 115Pancreatic Neoplasms 109Melanoma 96Squamous Cell Carcinoma of Head and Neck 93Recurrence 80Endometrial Neoplasms 78Carcinoma, Renal Cell 76Lymphoma, Non-Hodgkin 74Lymphoma 70Stomach Neoplasms 69Precursor Cell Lymphoblastic Leukemia-Lymphoma 69Carcinoma, Hepatocellular 67Glioblastoma 66Brain Neoplasms 64Sarcoma 62Glioma 62Uterine Cervical Neoplasms 59Head and Neck Neoplasms 59Triple Negative Breast Neoplasms 57Leukemia, Lymphocytic, Chronic, B-Cell 54Urinary Bladder Neoplasms 51

Interventions

Watchful Waiting 1Chemotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Pancreatic Neuroendocrine Tumors (pNET) × 30 days × Clear all
NCT07591493 2026-05-15

ADJUPANET

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Not yet recruiting
300 enrolled
EndocrineGastrointestinalNET

Pancreatic Neuroendocrine Tumors (pNET)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡